SCHEMBL14740539

SCHEMBL14740539

NC(=O)CCCCCCCCC(N)=O.NC(=O)CCCCCCCCC(N)=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.52
▸ SOAT1 P35610 2/20 0.52
▸ MEN1 O00255 2/20 0.52
▸ TP53 P04637 2/20 0.52
▸ CYP1A2 P05177 2/20 0.52
▸ CYP3A4 P08684 2/20 0.52
▸ CYP2C19 P33261 2/20 0.52
▸ FAAH O00519 1/20 0.52
▸ LMNA P02545 4/20 0.50
▸ PMP22 Q01453 3/20 0.50
▸ NFKB1 P19838 2/20 0.50
▸ TSHR P16473 1/20 0.50
▸ KDM4E B2RXH2 3/20 0.46
▸ ALOX15 P16050 3/20 0.45
▸ ALDH1A1 P00352 2/20 0.45
▸ RECQL P46063 2/20 0.45
▸ PLG P00747 1/20 0.45
▸ THRB P10828 1/20 0.45
▸ SLC6A2 P23975 1/20 0.45
▸ SLC6A3 Q01959 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2189282 1.00 KMT2A (0.52) KMT2ASOAT1MEN1TP53CYP1A2
SCHEMBL2088486 1.00 KMT2A (0.52) KMT2ASOAT1MEN1TP53CYP1A2
SCHEMBL636464 1.00 KMT2A (0.52) KMT2ASOAT1MEN1TP53CYP1A2
SCHEMBL380040 1.00 KMT2A (0.52) KMT2ASOAT1MEN1TP53CYP1A2
SCHEMBL25288050 1.00 KMT2A (0.52) KMT2ASOAT1MEN1TP53CYP1A2
SCHEMBL18911352 1.00 KMT2A (0.52) KMT2ASOAT1MEN1TP53CYP1A2
SCHEMBL25293705 1.00 KMT2A (0.52) KMT2ASOAT1MEN1TP53CYP1A2
SCHEMBL516952 1.00 KMT2A (0.52) KMT2ASOAT1MEN1TP53CYP1A2
SCHEMBL25293609 1.00 KMT2A (0.52) KMT2ASOAT1MEN1TP53CYP1A2
SCHEMBL376691 1.00 KMT2A (0.52) KMT2ASOAT1MEN1TP53CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9562183-B2 Use of compounds with nitrogen-containing functional groups for thermal energy storage ARKEMA FRANCE (FR) 2017-02-07 — — US disclosed
US-20130056175-A1 USE OF COMPOUNDS WITH NITROGEN-CONTAINING FUNCTIONAL GROUPS FOR THERMAL ENERGY STORAGE ARKEMA FRANCE (FR) 2013-03-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130056175-A1 USE OF COMPOUNDS WITH NITROGEN-CONTAINING FUNCTIONAL GROUPS FOR THERMAL ENERGY STORAGE S100A4, NUCB2, C9 KMT2A 3985/4885SOAT1 828/4885MEN1 1677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback